INTECH Investment Management’s Definium Therapeutics DFTX Stock Holding History

INTECH Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$939K	Sell	19,969 -5,021	-20%	-$124K	0.01%	1065
2026 Q1	$472K	Sell	24,990 -4,665	-16%	-$79.2K	﹤0.01%	1355
2025 Q4	$397K	Buy	29,655 +2,521	+9%	+$31.2K	﹤0.01%	1616
2025 Q3	$320K	Sell	27,134 -10,552	-28%	-$98.4K	﹤0.01%	1794
2025 Q2	$245K	Sell	37,686 -17,304	-31%	-$114K	﹤0.01%	1989
2025 Q1	$322K	Buy	54,990 +25,428	+86%	+$182K	﹤0.01%	1850
2024 Q4	$206K	Buy	29,562 +6,089	+26%	+$41.9K	﹤0.01%	2019
2024 Q3	$134K	Buy	+23,473	New	+$163K	﹤0.01%	1830

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

INTECH Investment Management's DFTX Position: Q2 2026 in Review

INTECH Investment Management reduced its Definium Therapeutics (DFTX) stake by 20% in Q2 2026, selling an estimated $124K and leaving 19,969 shares worth $939K. The position accounts for 0.01% of the portfolio, ranked #1065.

INTECH Investment Management first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

INTECH Investment Management held 19,969 shares of Definium Therapeutics worth $939K as of Q2 2026.
INTECH Investment Management sold 5,021 Definium Therapeutics shares in Q2 2026, an estimated $124K.
Definium Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1065 holding.
INTECH Investment Management first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.